DOI QR코드

DOI QR Code

Relationship between bronchial anthracofibrosis and endobronchial tuberculosis

  • Kim, Hyun Ji (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Kim, Sang Dong (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Shin, Dong Woo (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Bae, Soo Hyun (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Kim, Ah Lim (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Kim, Ji Na (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Jung, Seung Wook (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Lee, Byung Ki (Department of Internal Medicine, Daegu Fatima Hospital) ;
  • Kim, Yeon Jae (Department of Internal Medicine, Daegu Fatima Hospital)
  • Published : 2013.05.01

Abstract

Background/Aims: Various pulmonary diseases may be associated with bronchial anthracofibrosis (BAF). Our aim was to identify a relationship between BAF and endobronchial tuberculosis (EBTB). Methods: In total, 156 patients, diagnosed with EBTB using bronchoscopy, between June 1999 and May 2008, were included. Clinical and bronchoscopic findings between patients with BAF (n = 72, BAF group) and without BAF (n = 84, non-BAF) were analyzed retrospectively. Results: The crude odds ratio (OR) of BAF for EBTB was 8.88 (95% confidence interval, 6.37 to 12.37). On multivariate analysis, adjusting for age, history of biomass smoke exposure, and comorbidities, the most significant independent factor for EBTB was a history of biomass smoke exposure (adjusted OR, 17.471; adjusted p < 0.001). EBTB was more frequent in the right lung, particularly the right middle lobar bronchus, in the BAF group. Actively caseating, edematous-hyperemic, and ulcerative were the major types, with 77 (49%), 33 (21%), and 31 cases (20%), respectively. The BAF group had more ulcerative type, while the non-BAF group had more actively caseating type. The duration of EBTB treatment was similar between the groups. No significant difference was observed in the development of complications during treatment and posttreatment bronchostenosis between the groups. Conclusions: These findings suggest that BAF may be a risk factor for EBTB and affect the location and morphological type at the time of EBTB development.

Keywords

References

  1. Smith LS, Schillaci RF, Sarlin RF. Endobronchial tuberculosis: serial fiberoptic bronchoscopy and natural history. Chest 1987;91:644-647. https://doi.org/10.1378/chest.91.5.644
  2. Lee JH, Park SS, Lee DH, Shin DH, Yang SC, Yoo BM. Endobronchial tuberculosis: clinical and bronchoscopic features in 121 cases. Chest 1992;102:990-994. https://doi.org/10.1378/chest.102.4.990
  3. Kim YH, Kim HT, Lee KS, Uh ST, Cung YT, Park CS. Serial fiberoptic bronchoscopic observations of endobronchial tuberculosis before and early after antituberculosis chemotherapy. Chest 1993;103:673-677. https://doi.org/10.1378/chest.103.3.673
  4. Park EJ, Kim MO, Yang SC, et al. Clinical and bronchoscopic features of 280 patients with endobronchial tuberculosis (1990-2001). Korean J Med 2003;64:284-292.
  5. An JY, Lee JE, Park HW, et al. Clinical and bronchoscopic features in endobronchial tuberculosis. Tuberc Respir Dis 2006;60:532-539. https://doi.org/10.4046/trd.2006.60.5.532
  6. Kim HJ, Kim HS, Ma JE, et al. Clinical characteristics of endobronchial tuberculosis that develops in patients over 70 years of age. Tuberc Respir Dis 2007;63:412-416. https://doi.org/10.4046/trd.2007.63.5.412
  7. Kim YJ, Jung CY, Shin HW, Lee BK. Biomass smoke induced bronchial anthracofibrosis: presenting features and clinical course. Respir Med 2009;103:757-765. https://doi.org/10.1016/j.rmed.2008.11.011
  8. Chung MP, Lee KS, Han J, et al. Bronchial stenosis due to anthracofibrosis. Chest 1998;113:344-350. https://doi.org/10.1378/chest.113.2.344
  9. Cohen AG. Atelectasis of the right middle lobe resulting from perforation of tuberculous lymph nodes into bronchi in adults. Ann Intern Med 1951;35:820-835. https://doi.org/10.7326/0003-4819-35-4-820
  10. Van den Brande PM, Van de Mierop F, Verbeken EK, Demedts M. Clinical spectrum of endobronchial tuberculosis in elderly patients. Arch Intern Med 1990;150:2105-2108. https://doi.org/10.1001/archinte.1990.00390210081018
  11. Hwang J, Puttagunta L, Green F, Shimanovsky A, Barrie J, Long R. Bronchial anthracofibrosis and tuberculosis in immigrants to Canada from the Indian subcontinent. Int J Tuberc Lung Dis 2010;14:231-237.
  12. Chung HS, Lee JH. Bronchoscopic assessment of the evolution of endobronchial tuberculosis. Chest 2000;117:385-392. https://doi.org/10.1378/chest.117.2.385
  13. Mirsadraee M, Saeedi P. Anthracosis of lung: evaluation of potential underlying causes. J Bronchology 2005;12:84-87. https://doi.org/10.1097/01.laboratory.0000150873.99404.53
  14. Mishra VK, Retherford RD, Smith KR. Biomass cooking fuels and prevalence of tuberculosis in India. Int J Infect Dis 1999;3:119-129. https://doi.org/10.1016/S1201-9712(99)90032-2
  15. Perez-Padilla R, Perez-Guzman C, Baez-Saldana R, Torres-Cruz A. Cooking with biomass stoves and tuberculosis: a case control study. Int J Tuberc Lung Dis 2001;5:441-447.
  16. Pokhrel AK, Bates MN, Verma SC, Joshi HS, Sreeramareddy CT, Smith KR. Tuberculosis and indoor biomass and kerosene use in Nepal: a case-control study. Environ Health Perspect 2010;118:558-564.
  17. Kolappan C, Subramani R. Association between biomass fuel and pulmonary tuberculosis: a nested casecontrol study. Thorax 2009;64:705-708. https://doi.org/10.1136/thx.2008.109405
  18. Rajagopalan S. Tuberculosis and aging: a global health problem. Clin Infect Dis 2001;33:1034-1039. https://doi.org/10.1086/322671
  19. Zelikoff JT, Chen LC, Cohen MD, Schlesinger RB. The toxicology of the inhaled woodsmoke. J Toxicol Environ Health B Crit Rev 2002;5:269-282. https://doi.org/10.1080/10937400290070062
  20. Kim HY, Im JG, Goo JM, et al. Bronchial anthracofibrosis (inf lammatory bronchial stenosis with anthracotic pigmentation): CT findings. AJR Am J Roentgenol 2000;174:523-527. https://doi.org/10.2214/ajr.174.2.1740523
  21. Smart J. Endo-bronchial tuberculosis. Br J Tuberc Dis Chest 1951;45:61-68. https://doi.org/10.1016/S0366-0869(51)80003-0
  22. Pitchenik AE, Rubinson HA. The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis 1985;131:393-396.
  23. Sandoval J, Salas J, Martinez-Guerra ML, et al. Pulmonary arterial hypertension and cor pulmonale associated with chronic domestic woodsmoke inhalation. Chest 1993;103:12-20. https://doi.org/10.1378/chest.103.1.12
  24. Jokinen K, Palva T, Nuutinen J. Bronchial findings in pulmonary tuberculosis. Clin Otolaryngol Allied Sci 1977;2:139-148. https://doi.org/10.1111/j.1365-2273.1977.tb01613.x
  25. Sung UP, Kim SH, Shin JW, et al. The effect of steroid on the treatment of endobronchial tuberculosis. Tuberc Respir Dis 1995;42:130-141. https://doi.org/10.4046/trd.1995.42.2.130
  26. Lee JY, Kim CM, Moon DS, et al. The clinical features of endobronchial tuberculosis: a retrospective study on 201 patients for 6 years. Tuberc Respir Dis 1996;43:671-682. https://doi.org/10.4046/trd.1996.43.5.671
  27. Hoheisel G, Chan BK, Chan CH, Chan KS, Teschler H, Costabel U. Endobronchial tuberculosis: diagnostic features and therapeutic outcome. Respir Med 1994;88:593-597. https://doi.org/10.1016/S0954-6111(05)80007-1
  28. Chan HS, Pang JA. Effect of corticosteroids on deterioration of endobronchial tuberculosis during chemotherapy. Chest 1989;96:1195-1196. https://doi.org/10.1378/chest.96.5.1195
  29. Ip MS, So SY, Lam WK, Mok CK. Endobronchial tuberculosis revisited. Chest 1986;89:727-730. https://doi.org/10.1378/chest.89.5.727
  30. Gupta A, Shah A. Bronchial anthracofibrosis: an emerging pulmonary disease due to biomass fuel exposure. Int J Tuberc Lung Dis 2011;15:602-612. https://doi.org/10.5588/ijtld.10.0308
  31. Bruce N, Perez-Padilla R, Albalak R. Indoor air pollution in developing countries: a major environmental and public health challenge. Bull World Health Organ 2000;78:1078-1092.

Cited by

  1. The association between bronchial anthracofibrosis and pneumoconiosis: A retrospective cross‐sectional study vol.57, pp.2, 2013, https://doi.org/10.1539/joh.14-0177-oa
  2. Exposure to Mycobacterium tuberculosis during Flexible Bronchoscopy in Patients with Unexpected Pulmonary Tuberculosis vol.11, pp.5, 2013, https://doi.org/10.1371/journal.pone.0156385
  3. Bronchoscopic diagnostic procedures and microbiological examinations in proving endobronchial tuberculosis vol.42, pp.3, 2013, https://doi.org/10.1590/s1806-37562015000000134
  4. Clinical Manifestations of Fibrosing Mediastinitis in Chinese Patients vol.129, pp.22, 2013, https://doi.org/10.4103/0366-6999.193457
  5. Prediction of Anthracofibrosis Based on Clinico-Radiographic Findings vol.58, pp.2, 2013, https://doi.org/10.3349/ymj.2017.58.2.355
  6. Bronchial anthracofibrosis: The spectrum of radiological appearances vol.28, pp.3, 2018, https://doi.org/10.4103/ijri.ijri_339_17
  7. Pleural effusion resulting from bronchial tuberculosis : A case report vol.97, pp.40, 2013, https://doi.org/10.1097/md.0000000000012713
  8. The incidence of pulmonary tuberculosis in patients with anthracosis vol.6, pp.3, 2013, https://doi.org/10.3934/medsci.2019.3.210
  9. Evaluation of the Agreement Between the Tissue Sample and Bronchoalveolar Lavage (BAL) Fluid in the Diagnosis of Tuberculosis in Patients with Anthracosis vol.15, pp.4, 2013, https://doi.org/10.2174/1573398x15666190719162914